Impact of Visceral Adiposity as Well as Sarcopenic Factors on Outcomes in Patients Undergoing Liver Resection for Colorectal Liver Metastases

被引:36
作者
Kobayashi, Atsushi [1 ]
Kaido, Toshimi [1 ]
Hamaguchi, Yuhei [1 ]
Okumura, Shinya [1 ]
Shirai, Hisaya [1 ]
Kamo, Naoko [1 ]
Yagi, Shintaro [1 ]
Taura, Kojiro [1 ]
Okajima, Hideaki [1 ]
Uemoto, Shinji [1 ]
机构
[1] Kyoto Univ, Grad Sch Med, Div Hepatobiliary Pancreat & Transplant Surg, Dept Surg,Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan
关键词
SKELETAL-MUSCLE; EICOSAPENTAENOIC ACID; HEPATIC RESECTION; PROGNOSTIC-FACTOR; TISSUE CONTENT; MASS INDEX; CANCER; SURVIVAL; HEPATECTOMY; MANAGEMENT;
D O I
10.1007/s00268-017-4255-5
中图分类号
R61 [外科手术学];
学科分类号
摘要
We have reported preoperative low skeletal muscularity as an independent risk factor for poor outcomes after liver transplantation, resection of hepatocellular carcinoma, pancreatic cancer and extrahepatic biliary malignancies. However, the impacts of visceral adiposity and muscularity on outcomes after liver resection for colorectal liver metastases (CLM) have not been fully investigated. We retrospectively analyzed 124 patients undergoing primary liver resection for CLM between 2005 and 2014. Using preoperative computed tomography at the third lumbar vertebra level, skeletal muscle and abdominal adipose tissue were evaluated by skeletal muscle index (SMI), intramuscular adipose tissue content (IMAC) and visceral-to-subcutaneous adipose tissue area ratio (VSR), respectively. Impacts of preoperative SMI, IMAC and VSR on outcomes after liver resection for CLM were investigated. Low SMI and high VSR were not significantly associated with poor overall or recurrence-free survivals (P = 0.324 and P = 0.106, P = 0.964 and P = 0.738, respectively). Overall survival rate tended to be lower in patients with high IMAC than in patients with normal IMAC (P = 0.054). Recurrence-free survival rate did not differ significantly between high and normal IMAC (P = 0.721). Multivariate analysis showed that low SMI, high IMAC and high VSR were not significant risk factors for death or recurrence after liver resection for CLM. Neither preoperative visceral adiposity nor low muscularity were poor prognostic factors in patients undergoing liver resection for CLM.
引用
收藏
页码:1180 / 1191
页数:12
相关论文
共 42 条
  • [31] Impact of the preoperative quantity and quality of skeletal muscle on outcomes after resection of extrahepatic biliary malignancies
    Okumura, Shinya
    Kaido, Toshimi
    Hamaguchi, Yuhei
    Fujimoto, Yasuhiro
    Kobayashi, Atsushi
    Iida, Taku
    Yagi, Shintaro
    Taura, Kojiro
    Hatano, Etsuro
    Uemoto, Shinji
    [J]. SURGERY, 2016, 159 (03) : 821 - 833
  • [32] Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer
    Okumura, Shinya
    Kaido, Toshimi
    Hamaguchi, Yuhei
    Fujimoto, Yasuhiro
    Masui, Toshihiko
    Mizumoto, Masaki
    Hammad, Ahmed
    Mori, Akira
    Takaori, Kyoichi
    Uemoto, Shinji
    [J]. SURGERY, 2015, 157 (06) : 1088 - 1098
  • [33] Global cancer statistics, 2002
    Parkin, DM
    Bray, F
    Ferlay, J
    Pisani, P
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2005, 55 (02) : 74 - 108
  • [34] Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis
    Peng, Peter D.
    van Vledder, Mark G.
    Tsai, Susan
    de Jong, Mechteld C.
    Makary, Martin
    Ng, Julie
    Edil, Barish H.
    Wolfgang, Christopher L.
    Schulick, Richard D.
    Choti, Michael A.
    Kamel, Ihab
    Pawlik, Timothy M.
    [J]. HPB, 2011, 13 (07) : 439 - 446
  • [35] Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
    Prado, Carla M. M.
    Liefers, Jessica R.
    McCargar, Linda J.
    Reiman, Tony
    Sawyer, Michael B.
    Martin, Lisa
    Baracos, Vickie E.
    [J]. LANCET ONCOLOGY, 2008, 9 (07) : 629 - 635
  • [36] Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial
    Read, Jane A.
    Beale, Philip J.
    Volker, Dianne H.
    Smith, Narelle
    Childs, Annabel
    Clarke, Stephen J.
    [J]. SUPPORTIVE CARE IN CANCER, 2007, 15 (03) : 301 - 307
  • [37] Sarcopenia: Origins and clinical relevance
    Rosenberg, IH
    [J]. JOURNAL OF NUTRITION, 1997, 127 : S990 - S991
  • [38] Adipocytokines: mediators linking adipose tissue, inflammation and immunity
    Tilg, Herbert
    Moschen, Alexander R.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2006, 6 (10) : 772 - 783
  • [39] Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases
    van der Geest, Lydia G. M.
    Lam-Boer, Jorine't
    Koopman, Miriam
    Verhoef, Cees
    Elferink, Marloes A. G.
    de Wilt, Johannes H. W.
    [J]. CLINICAL & EXPERIMENTAL METASTASIS, 2015, 32 (05) : 457 - 465
  • [40] Body composition and outcome in patients undergoing resection of colorectal liver metastases
    van Vledder, M. G.
    Levolger, S.
    Ayez, N.
    Verhoef, C.
    Tran, T. C. K.
    IJzermans, J. N. M.
    [J]. BRITISH JOURNAL OF SURGERY, 2012, 99 (04) : 550 - 557